Authors


Caryn Fenner

Latest:

Timeline for mRNA Vaccine Development for Rift Valley Fever

Caryn Fenner and Petro Terblanche outline Afrigen's clinical trial plans, local partnerships, and vaccine pipeline.


Shaun Holt

Latest:

Nationwide Avian Flu Response Gains Momentum, Yet Urgent Action Remains Essential

The ongoing H5N1 avian flu outbreak has severely impacted U.S. poultry and dairy industries, prompting a $1 billion USDA response strategy that includes biosecurity, vaccination research, and innovation funding. With growing concern over viral mutations affecting humans and livestock, rapid, field-based diagnostic tools offer critical support in accelerating detection and containment efforts.


William Schaffner, MD

Latest:

Federal Government Changes Course Again on COVID-19 Vaccine Policy

After the leaders of the NIH, FDA, and HHS made an announcement stating that both pregnant women and children were going to be taken off the COVID-19 immunization schedule, they decided to offer a new designation for the latter group, making it a shared decision between providers and patients.


Ryan Mynatt, PharmD, BCPS

Latest:

Tricky Infusion Issues and Potential Solutions: OPAT Edition

Outpatient parenteral antimicrobial therapy (OPAT) offers benefits for patients as well as providing cost effectiveness; however, it is not without its challenges. Two clinicians provide insights on this modality.


Harmony Garges, MD, MPH

Latest:

Apretude PrEP Shows High Efficacy, Safety in Diverse Studies

New data at CROI 2025 shows zero cases of HIV acquisition reported with Apretude (cabotegravir long-acting (CAB LA) for PrEP in varied clinical settings and populations in 2 implementation studies in the US and Brazil.


Deema Abdelrahman, PharmBSc, BCIDP

Latest:

Antimicrobial Stewardship: How to Extend a Solid Handshake

In the latest column from SIDP, handshake stewardship prioritizes face-to-face communication between frontline providers to enable feedback to assess the appropriateness of prescribed antimicrobials.


Evelyn Wu, MD

Latest:

Expanding Tick-Borne Disease Trends in New Jersey

Evelyn Wu, MD, reveals a rise in tick-borne diseases in New Jersey over the past two decades and correlations with the influence of warming climate conditions.


Nicole Bradley, PharmD, BCPS, BCIDP

Latest:

Shifting to Shorter Courses of Antibiotic Therapy for Common Pediatric Infections

In the latest SIDP column, two clinicians provide information on recent studies and guidelines directed at antibiotic durations in this patient population.


Stephen Pagkalinawan, MD

Latest:

A Case of Hemophagocytic Lymphohistiocytosis Secondary to Cytomegalovirus Infection

There have been sporadic cases Hemophagocytic Lymphohistiocytosis, associated with Cytomegalovirus Infection infection, suggesting that CMV may cause clinically significant disease beyond mononucleosis in immunocompetent individuals.



Esther Y. Bae, PharmD, BCIDP

Latest:

Impact of Inpatient Pharmacist Review of Discharge Antibiotics

A food for thought as an ambulatory antibiotic stewardship initiative.


John M. McLaughlin, PhD

Latest:

Evaluating the Efficacy of Paxlovid in High-Risk Patients with Pre-Existing Immunity

John McLaughlin, PhD, examines high-risk individuals with prior SARS-CoV-2 immunity and presents that Paxlovid reduces the risk of hospitalization, death, and severe symptoms, highlighting its ongoing value for high-risk patients in a post-peak pandemic landscape.


Dianne Nguyen, MD

Latest:

Vowst Maintains Consistent Safety Profile in rCDI Patients With Comorbidities

At MAD-ID, Dianne Nguyen, MD, shares Phase 3 data showing consistent tolerability of the microbiome therapy across high-risk patient populations


Ali Hassan, PharmD

Latest:

Considerations for Antimicrobial Stewardship While Optimizing Therapy for a Patient With HIV

Here is a case study involving a patient with the virus and the clinical approach in thinking about appropriate treatment while keeping stewardship in mind.



Freda Kreier

Latest:

Internal Tremors: Adding to the List of Long COVID Symptoms

Internal tremors are a newly recognized and troubling symptom of Long COVID, experienced by over one-third of participants in a Yale-based study


Seung Ha, PharmD

Latest:

Discussing Outpatient COVID-19 Treatments

Here is a look at some of the treatment alternatives, which can offer simpler logistics and cost considerations.


Nicholas Rebold, PharmD, BCIDP, AAHIVP, MPH

Latest:

The Role of Rifampin in Bone and Joint Infections

In the latest column from the Society of Infectious Diseases Pharmacists (SIDP), here is a discussion on the use of rifampin as an adjunctive antibiotic treatment for patients with diabetic foot osteomyelitis.


David Richards

Latest:

Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients

David Richards emphasized the therapy’s potential to enhance antibiotic effectiveness by targeting bacterial biofilms, a significant challenge in treatment.


Nicolás Cortés-Penfield, MD

Latest:

Updates and Controversies in Necrotizing Soft Tissue Infections

Changes in microbiology and antimicrobial resistance patterns warrant reevaluation of our current therapies for this condition.


Christian John Lillis

Latest:

Education and Advocacy in DC: The PLF C Diff Summit and Lobby Day

The Peggy Lillis Foundation's (PLF) CEO and Cofounder Christian John Lillis talks about these important events happening in the capital at the end of this month.


Sara Haddad, MD

Latest:

Ruptured Echinococcal Pulmonary Cyst

Here is a review of this specific case.


Alexander Laurenson

Latest:

Computational Model Maps Over 67,000 Malaria Epitopes to Improve Vaccine Targeting

Alexander Laurenson presents T-cell-focused tool at the 2025 Vaccinology Conference using data from 18 countries and 748 HLA alleles to address immune diversity in Africa.


Daniel Tsang, MD

Latest:

Ruptured Echinococcal Pulmonary Cyst

Here is a review of this specific case.


Larry Sutton, MD, PhD

Latest:

Targeting C difficile with Oxygen-Based Therapy

Larry Sutton, MD, PhD, discussed how oxygen affects C. difficile and provides anti-inflammatory effects in the gut, with potential applications for gastrointestinal diseases.


Rachel Zetts, MS

Latest:

Antibiotic Stewardship Programs Help Curb Superbug Threat by Leveraging Data

The OASIS platform will help outpatient facilities use prescribing data to improve patient care.


Amesh A. Adalja, MD, FIDSA

Latest:

A Personnel Problem: We Need More Antimicrobial Researchers, Infectious Disease Clinicians

A decreasing number of researchers and open positions for infectious disease clinicians and limited residency matches are underlying issues that should be addressed to meet the needs around antimicrobial development and clinical care. Amesh Adalja, MD, FIDSA, discusses some of the challenges behind it.


Timothy Ritter, MD

Latest:

A Clinician’s Perspective on Rebyota for Recurrent C Diff Treatment

Timothy Ritter, MD, provides his insights on using the live biotherapeutic product and what both patients and clinicians can expect in terms of safety and efficacy.


Jen Brull, MD, FAAFP

Latest:

Clinicians Discuss the State of Vaccines Today

A panel discusses how vaccine policy under new federal government policies, why misinformation has flourished and what individual providers can do to win back patient trust.


Abigail Lewis

Latest:

Gilead Expands Global Access to Lenacapavir With New HIV Prevention Partnership

Gilead Sciences has partnered with the Global Fund to supply up to 2 million doses of its long-acting HIV prevention drug, lenacapavir, to low and lower-middle income countries.

© 2025 MJH Life Sciences

All rights reserved.